SeaSpine Growth Driven by New Products and Geographic Expansion

SeaSpine's logo

SeaSpine reported 3Q20 orthopedic revenue of USD $43.2 million, +8.3% vs. 3Q19. Unlike some peers, SeaSpine saw surgical volumes accelerate throughout the quarter despite most surgeons depleting their backlogs early in 3Q. The company attributes the acceleration to its cadence of new products, contracting wins in large health systems and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us